NASDAQ:OBLN Shareholder Notice: Lawsuit Alleges Misleading Statements by Obalon Therapeutics Inc
An investor, who purchased NASDAQ:OBLN shares filed a lawsuit against Obalon Therapeutics Inc over alleged violations of Federal Securities Laws.
View full press release